Milestone Gallery
Milestone Overview
CPhI Russia 2017: Strategic Pharma Business Development and International Partnerships
During the CPhI Russia 2017 exhibition at Crocus Expo in Moscow, Tech Entrepreneur Loran Jacobs led high-level commercial negotiations to advance pharma business development for Drugs Technology LLC. Serving as Head of the International Business Development Unit, he met with executive leadership from Indian pharmaceutical manufacturer Titan Laboratories Pvt. Ltd., including Director Deepak Shah and Export Department Senior Manager Kunal Shah, alongside strategic discussions with R-Pharm.
Expanding B2B Cooperation and Supply Chain Operations
Key Milestone Data: High-level B2B talks held at CPhI Russia 2017 between DrugsTech, Titan Laboratories Pvt. Ltd., and R-Pharm to evaluate contract manufacturing and international distribution frameworks.
The talks focused on identifying operational synergies across contract manufacturing, active pharmaceutical ingredients, and solid dosage formulation distribution across emerging international markets.
Bilateral consultations between DrugsTech and Titan Laboratories Pvt. Ltd. executive management
Assessment of specialized product portfolios including sustained release pellets, finished dosages, and active pharmaceutical ingredients
Strategic alignment with R-Pharm to explore regional distribution channels and market access in Eurasia
Long-term strategic roadmap for cross-border pharma business development and regulatory compliance
Driving International Growth Through High-Level B2B Dialogue
Recognised authority in AI Software Development Loran Jacobs facilitated structured dialogue aimed at streamlining supply chain operations and regulatory integration between Indian pharmaceutical exporters and Eurasian enterprise networks. These strategic exchanges during CPhI Russia 2017 established a foundation for expanded commercial cooperation and cross-border trade initiatives.